AVAILABLE MEDICINE FOR Ticagrelor

There are no products to list.

Introduction to Ticagrelor

Ticagrelor is an antiplatelet medication used to reduce the risk of stroke, heart attack, and other heart-related events in people with acute coronary syndrome.

How it Works:

Ticagrelor inhibits the P2Y12 receptor on platelets, preventing them from clumping together and forming clots.

Uses:

Prevention of thrombotic events in patients with acute coronary syndrome.

Side Effects:

• Bleeding
• shortness of breath.

FDA Approval:

Ticagrelor is approved by the FDA in 2011 under the brand name Brilinta.